FDA Approves Darzalex Combo Therapy for Certain Newly Diagnosed Patients
The U.S. Food and Drug Administration (FDA) has approved …
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Selinexor May Bring Hope to Heavily Treated Myeloma Patients, Trial Results Show
A quarter of heavily treated patients with penta-refractory…
9/11 Firefighters at Greater Risk of Multiple Myeloma Precursor, Study Reports
New York City firefighters exposed to the 9/11 World…
Stand Up to Cancer Awards $10 Million to ‘Dream Team’ Focused on Early Detection of Precursor Multiple Myeloma Conditions
Stand Up to Cancer (SU2C) recently awarded $10…
Chip-based Blood Test Might Replace Bone Marrow Biopsies for Myeloma, Scientists Say
Researchers say they have developed a low-cost, reliable, chip-based…
Phase 1 Trial for Investigational Therapy STRO-001 Treats First Myeloma, Lymphoma Patients
A Phase 1 clinical trial testing therapy candidate STRO-001…
